“Following the withdrawal of…
“Following the withdrawal of Ocaliva from the U.S. market, we [...]
“Following the withdrawal of Ocaliva from the U.S. market, we [...]
Plus, the subway stop that’s also a museum.
Los científicos no están del todo seguros de qué causa [...]
Tuesday, the U.S. regulator greenlit GSK’s depemokimab, an ultra-long-acting biologic, [...]
Scientists aren’t entirely sure what causes rosacea, or why it [...]
As both Novo Nordisk and Eli Lilly race to develop [...]
The FDA has approved Enhertu combined with Roche’s Perjeta as [...]
The FDA has signed off on Milestone Pharmaceuticals’ Cardamyst, a [...]
The sexually transmitted disease has become increasingly resistant to existing [...]
After three decades of no new antibiotics for the treatment [...]